Family Medicine Doctors in Valley City, ND Accepting Medicare
10 Family Medicine doctors found. Showing 1 - 10
 James B Buhr, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 Fax: 701-845-6150 |
 Genevieve M Goven, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 Fax: 701-845-6150 |
Chelsea Renae Traverse, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 |
Fredrick Mitzel, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1000 W Main St, Valley City, ND 58072 Phone: 701-845-8060 Fax: 701-845-8067 |
Bradley A Braunagel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 Fax: 701-845-6150 |
Paul L Diegel, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 W Main St, Valley City, ND 58072 Phone: 701-845-8060 Fax: 701-845-8067 |
Dr. David L Hochhalter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 Fax: 701-845-6150 |
Tanya L Diegel, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 132 4th Ave Ne, Valley City, ND 58072 Phone: 701-845-8060 |
Glenn M Thoreson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 Fax: 701-845-6150 |
Ashley M Horner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6000 |
News Archive
Millennium submits two VELCADE sNDAs to FDA
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).
Chrysler saves millions on workers healthcare
The Chrysler Group will save itself tens of millions of dollars in health costs through changes it has won from the United Auto Workers union while costing employees and their family up to $1,000 in health care deductibles, according to a deal reported in the Detroit News, which it said is outlined in a March 10 letter to workers, but not publicly announced by either the union or the company.
Census shows health insurance coverage winners, losers
Among the 25 biggest cities, uninsured rates last year ranged from almost 25 percent in Miami and 23 percent in Houston to just more than 4 percent in Boston and 7.5 percent in Pittsburgh, according to Census data.
New research sheds light on Sudden Infant Death Syndrome
New research published today in The Journal of Physiology sheds light on areas of the brain thought to be the root cause of Sudden Infant Death Syndrome - the poorly understood condition also known as 'cot death'.
› Verified 5 days ago